Related Experiment Video
Updated: Sep 1, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Sarcoidosis developing after COVID-19: A case report
Dujrath Somboonviboon1, Anan Wattanathum1, Narumon Keorochana2
1Pulmonary and Critical Care Division, Department of Medicine Phramongkutklao Hospital Bangkok Thailand.
A case study suggests a link between COVID-19 and sarcoidosis, an inflammatory condition. This viral infection may trigger immune dysregulation, potentially leading to sarcoidosis development post-illness.
Area of Science:
- Immunology
- Pulmonology
- Ophthalmology
Background:
- COVID-19 (Coronavirus disease 2019) is linked to various autoimmune conditions.
- Sarcoidosis is characterized by granulomatous inflammation, potentially triggered by immune dysregulation and environmental factors.
Observation:
- A patient hospitalized for SARS-CoV-2 infection developed symptoms ten weeks post-illness.
- Chest CT revealed enlarged lymph nodes (hilar, paratracheal, subcarinal).
- Endobronchial ultrasound with transbronchial needle aspiration (EBUS-TBNA) confirmed non-necrotizing granulomas.
Findings:
- The patient was diagnosed with sarcoidosis.
- Ophthalmological examination showed panuveitis and papillitis in both eyes.
- These findings suggest sarcoidosis as a sequela of COVID-19.
Implications:
- This case highlights a potential association between SARS-CoV-2 infection and the subsequent development of sarcoidosis.
- The findings suggest that COVID-19 might dysregulate inflammatory processes, contributing to sarcoidosis pathogenesis.
- Further research is necessary to establish and understand this viral-immune connection.
More Related Videos
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pneumonia II: Pathophysiology